Business Update19 May 2026, 05:01 pm
Ajanta Pharma Revises Investor Conference Schedule
AI Summary
Ajanta Pharma Ltd has revised its schedule for Analyst / Institutional Investor Meetings, initially announced under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The dates of two conferences were inadvertently interchanged in the earlier intimation. The corrected schedule includes participation in the 360 ONE Capital(B&K) Annual Investor Conference on May 29, 2026, and the ICICI Securities India Investor Conference on June 8, 2026. The schedule is subject to change due to unforeseen circumstances, and discussions will be based on publicly available information.
Key Highlights
- Ajanta Pharma revises its investor conference schedule.
- Dates for two conferences were interchanged in the initial announcement.
- Revised schedule includes 360 ONE Capital and ICICI Securities conferences.
- Meetings will focus on already published information.
Price Impact
More from AJANTPHARM